Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016)
Jazz Pharmaceuticals (JAZZ) posted quarterly Land & Improvements of $1.8 million for Q1 2016, up 33.19% year-over-year from $1.4 million in Q2 2015, and up 3.55% quarter-over-quarter from $1.8 million in Q4 2015.
Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $1.8 million for Q1 2016.
- In Q1 2016, Land & Improvements rose 33.19% year-over-year to $1.8 million; the TTM figure through Mar 2016 stood at $1.8 million (up 33.19% YoY), while the FY2015 annual figure was $1.8 million, up 14.74% from the prior year.
- Land & Improvements for Q1 2016 stood at $1.8 million, up from $1.8 million in the prior quarter.
- The five-year high for Land & Improvements was $1.8 million in Q1 2016, with the low at $1.4 million in Q1 2015.
- The 3-year median for Land & Improvements is $1.7 million (2014), against an average of $1.7 million.
- The sharpest annual moves came in 2015 and 2016: Land & Improvements retreated 17.76% in 2015, then jumped 33.19% in 2016.
- Jazz Pharmaceuticals' Land & Improvements stood at $1.5 million in 2014, then rose by 14.74% to $1.8 million in 2015, then rose by 3.55% to $1.8 million in 2016.
- Business Quant data shows JAZZ's Land & Improvements at $1.8 million in Q1 2016, $1.8 million in Q4 2015, and $1.8 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 1.84 Mn |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | 1.78 Mn |
| Jun 30, 2015 | 1.69 Mn |
| Mar 31, 2015 | 1.38 Mn |
| Dec 31, 2014 | 1.55 Mn |
| Sep 30, 2014 | 1.61 Mn |
| Jun 30, 2014 | 1.69 Mn |
| Mar 31, 2014 | 1.68 Mn |